Vir Biotechnology Inc (VIR)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-521,960	-533,344	-483,040	-539,437	-615,117	-600,747	-262,022	-143,740	515,837	1,142,694	1,077,810	1,216,116	528,584	-102,319	-297,356	-390,336	-298,665	-256,787	-220,492	-223,253
Revenue (ttm)	US$ in thousands	73,109	78,618	72,140	56,343	46,679	51,681	427,211	397,246	1,580,474	2,368,441	2,099,722	2,316,395	1,087,060	277,605	175,080	67,363	67,245	67,315	67,364	1,181
Net profit margin		-713.95%	-678.40%	-669.59%	-957.42%	-1,317.76%	-1,162.41%	-61.33%	-36.18%	32.64%	48.25%	51.33%	52.50%	48.63%	-36.86%	-169.84%	-579.45%	-444.14%	-381.47%	-327.31%	-18,903.73%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-521,960K ÷ $73,109K
= -713.95%

The net profit margin of Vir Biotechnology Inc has fluctuated significantly over the past few years. The company experienced negative net profit margins in the range of -18,903.73% to -1,317.76% from March 2020 to December 2023. This indicates that the company was incurring significant losses relative to its revenue during this period.

However, there was a positive turnaround in the net profit margin starting from March 2024, with the margin improving to -957.42% and progressively increasing to -713.95% by December 2024. While these values still imply that the company was not profitable, the decreasing negative percentages suggest that the company's financial performance may be improving.

It's essential for investors and stakeholders to closely monitor this metric to assess the company's profitability and financial health going forward.